Intuitive Surgical Placed 546 da Vinci Systems Last Quarter. Why Wall Street's Sell-Off Misses the Point.

ISRG shares fell despite strong quarterly results, and the sell-off may be mispricing what drives the business. The company placed 546 da Vinci systems last quarter, yet system sales make up only 25% of revenue.

The other 75% comes from services, instruments, and accessories tied to an installed base of 12,094 systems. That recurring stream is the core of the model, not the one-time robot sale. Procedure volumes rose 15% year-over-year, which supports ongoing demand for instruments and accessories used on that base.

Competitive pressure is real: MDT and JNJ are both pursuing surgical robotics. The source frames the market as still in early adoption, which suggests room for growth even with rivals entering. Interpretation: the sell-off appears to price the headline competitive threat while discounting the revenue annuity attached to 12,094 installed systems.

The stock's drop on a quarter that included 546 placements and 15% procedure growth reflects a gap between price action and operating data. Whether that gap closes depends on whether procedure growth holds.